From Words to Outcomes: Transforming Care for Alcohol-Associated Liver Disease, Part 2

Nov 06 2026
Convention Center: Bluebird Ballroom 1B
2:00 PM - 3:30 PM
Captured/recorded session Recorded
CE Credits CE Credits

Description

Jointly planned by the Alcohol-Associated Liver Disease and Public Health/Health Delivery Special Interest Groups, this 2-part symposium examines transformation of care for alcohol-associated liver disease (ALD) through the lens of health delivery and engagement to improve outcomes. Key concepts explored in part 2 of the symposium include:

  • Leveraging biomarkers in alcohol use disorder and ALD screening and treatment
  • Impact of cardiometabolic risk factors in ALD
  • Strategies to implement alcohol use care in clinical practice
  • Leveraging health impacts of alcohol beyond the liver to increase care engagement
  • Alcohol policy as liver disease prevention and treatment

Presentations

2:00 PM - 2:15 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Alcohol Policy as Liver Disease Prevention and Treatment

Grant Wyper, PhD | Presenter
2:15 PM - 2:30 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Leveraging Biomarkers in Alcohol Use Disorder and Alcohol-Associated Liver Disease Screening and Treatment

Juan Pablo Arab, MD, FRCPC | Presenter
2:30 PM - 2:45 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Impact of Cardiometabolic Risk Factors in Alcohol-Associated Liver Disease

Brian P Lee, MD MAS | Presenter
2:45 PM - 3:00 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Strategies to Implement Alcohol Use Care at Your Center

Shari Rogal, MD, MPH, FAASLD | Presenter
3:00 PM - 3:15 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Leveraging Health Impacts of Alcohol Beyond the Liver to Increase Care Engagement

Gene Y. Im, MD, FAASLD | Presenter

Objectives

  • Explain the population-level impacts of minimum-unit pricing (MUP) on alcohol-associated outcomes.
  • Examine how biomarkers of alcohol and liver fibrosis can be leveraged to improve care.
  • Summarize how alcohol affects health beyond the liver and how cardiometabolic risk factors impact alcohol-associated liver disease.